Vote Scores
Filings read through

Anavex Life Sciences Corp.: how funds voted at the meeting of 18 Jun 2024

Ticker
AVXL
Meeting
Season
year to 30 June 2024
Filers reporting
209
Ballot items
4

209 filers on Form N-PX reported votes at the Anavex Life Sciences Corp. meeting of 18 Jun 2024. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of Anavex Life Sciences Corp. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    6 nominees. 92.5% of the reported votes are for. 22 filers withheld from or voted against at least one nominee.

    709 vote records from 64 filers. 0 of the 64 filers that marked the item voted against management.

    • Positions of 26 fund families
    • For 25
    • Split or no vote 1
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    295 vote records from 207 filers. 16 of the 200 filers that marked the item voted against management. 7 filers gave no management mark.

    • Positions of 36 fund families
    • For 34
    • Against 2
    • Against management 2
  3. Item 3: Audit-related items (auditor ratification)

    119 vote records from 64 filers. 0 of the 64 filers that marked the item voted against management.

    • Positions of 26 fund families
    • For 26
  4. Item 4: Shareholder Proposal regarding Shareholder Opportunity to Vote on Excessive Golden Parachutes.

    117 vote records from 62 filers. 39 of the 62 filers that marked the item voted against management.

    • Positions of 25 fund families
    • For 18
    • Against 7
    • Against management 18

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Anavex Life Sciences Corp., meeting of 18 Jun 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor4. Proposal
AllianceBernsteinForNo reportNo report
American CenturyAgainst, against managementForFor, against management
BlackRock and iSharesForForAgainst
BNY MellonForNo reportNo report
Brighthouse FundsForForFor, against management
Charles SchwabForForFor, against management
Columbia ThreadneedleForNo reportNo report
DimensionalForForFor, against management
DWSForForFor, against management
EquitableForForFor, against management
FidelityForForAgainst
Franklin TempletonForNo reportNo report
Global XForForNo report
Goldman SachsForNo reportNo report
Guggenheim and RydexForForFor, against management
InvescoForForFor, against management
J.P. MorganForNo reportNo report
Janus HendersonForNo reportNo report
John Hancock and ManulifeForForFor, against management
Lincoln FinancialForForAgainst
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementForFor, against management
NationwideForForFor, against management
Natixis and Loomis SaylesForNo reportNo report
Neuberger BermanForNo reportNo report
Northern Trust and FlexSharesForForFor, against management
Nuveen and TIAAForForFor, against management
Pacific Life fundsForForAgainst
PGIM and PrudentialForNo reportNo report
PrincipalForForFor, against management
ProShares and ProFundsForForFor, against management
SEIForForFor, against management
State Street and SPDRForForAgainst
T. Rowe PriceForForAgainst
VanguardForForAgainst
Victory CapitalForForFor, against management
VoyaForForFor, against management

Questions

How many filers reported votes at the Anavex Life Sciences Corp. meeting?
209 Form N-PX filers reported votes at the meeting of 18 Jun 2024. On say-on-pay, 16 of 200 filers that marked the item voted against management (8.0%). The filings show one separate proposal from security holders.
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Anavex Life Sciences Corp. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Anavex Life Sciences Corp. with a meeting date within three days of 18 Jun 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .